Palmitoyléthanolamide SEVIPHARM 400 mg - 90 gélules
Food supplement declared in France, decision dated 20 August 2025
Palmitoyléthanolamide SEVIPHARM 400 mg - 90 gélules, from DITRAGEN DEVELOPMENT, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Palmitoyléthanolamide 1,200 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- SEVIPHARM
- Food business operator placing the product on the market
- DITRAGEN DEVELOPMENT
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1 à 3 gélules
- Directions for use
- Prendre 1 à 3 gélules par jour, à avaler avec un grand verre d’eau
- Intended populations
- Men and women aged 18 and over, People over 60
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Mood, Sleep, Nervous system, Joints
- Flavourings
- Sans saveur
Declaration 338965, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Substances
| Name | Per day |
|---|---|
| Palmitoyléthanolamide | 1,200 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
• Les compléments alimentaires doivent être utilisés dans le cadre d’un mode de vie sain et ne pas être utilisés comme substituts d’un régime alimentaire varié et équilibré • Ne pas dépasser la dose journalière indiquée • Tenir hors de portée des jeunes enfants • Ce produit est déconseillé aux femmes enceintes ou allaitantes, aux personnes ayant des troubles de la déglutition (risque de fausse route), ainsi qu’aux enfants de moins de 12 ans • Conserver dans un endroit frais, sec et à l’abri de la lumière
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : SEVIPHARM
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Palmitoyléthanolamide SEVIPHARM 400 mg - 90 gélules: composition and regulation”, https://compoatlas.com/en/supplements/products/338965-palmitoylethanolamide-sevipharm-400-mg-90-gelules, updated 15 November 2026.